Oxidative Status in Adult Anorexia Nervosa Patients and Healthy Controls-Results from a Cross-Sectional Pilot Study.
Jolana Wagner-SkacelFiona HaidacherMarkus WienerKaroline PahsiniSabine MarinschekTheresa LahousenWillibald WonischSusanne BengesserMary I ButlerSonja LacknerAndreas MeinitzerDietmar EnkoSabrina MorklPublished in: Antioxidants (Basel, Switzerland) (2022)
Oxidative stress describes an imbalance of reactive oxygen species (ROS) and antioxidative defence systems. Recently, the consequences of oxidative stress have become a central field of research and have been linked to the genesis of multiple psychiatric diseases. Some oxidative stress parameters have not been investigated before in anorexia nervosa (AN) patients, including the gut microbiota-derived metabolite trimethylamine N-oxide (TMAO) and polyphenols (PPm). In this cross-sectional pilot study, we evaluated these markers together with total peroxides (TOC), antioxidative capacity (TAC), endogenous peroxidase activity (EPA) and antibodies against oxidized LDL (oLAb) in serum samples of 20 patients with AN compared to 20 healthy controls. The antioxidative capacity was significantly decreased in AN patients, with a mean TAC of 1.57 mmol/L (SD: ±0.62); t (34) = -2.181, p = 0.036) compared to HC (mean = 1.91 mmol/L (SD: ±0.56), while the other investigated parameters were not significantly different between the two groups. In AN patients, TAC correlated with EPA (r sp = -0.630, p = 0.009). This study suggests that there is an antioxidative deficiency in AN patients. In this respect, there is a demand for interventional studies to determine whether antioxidants can be used as add-on therapy in the treatment of AN.
Keyphrases
- end stage renal disease
- oxidative stress
- newly diagnosed
- ejection fraction
- chronic kidney disease
- dna damage
- reactive oxygen species
- peritoneal dialysis
- prognostic factors
- anorexia nervosa
- stem cells
- patient reported outcomes
- anti inflammatory
- hydrogen peroxide
- nitric oxide
- bone marrow
- mass spectrometry
- mesenchymal stem cells
- high speed
- patient reported